What is public longevity infrastructure and why it matters?
Public longevity infrastructure is everything a government builds and funds to add healthy years, not just years: tobacco and alcohol laws, vaccination and screening programmes, blood-pressure control, primary care and pharmacies, clean air and walkable neighbourhoods, falls-prevention services, and research. It matters because people are living longer but spending more of the extra time in poor health — the gap has widened almost everywhere and is widest in rich countries — and because promises alone do not fix it, as the UK found when it pledged five extra healthy years and then recorded its worst result on record.
Public longevity infrastructure is the set of laws, budgets, services and physical environments a government uses to extend healthy life expectancy rather than just life expectancy — and it matters now because the two have been diverging: the Global Burden of Disease 2023 analysis found the global morbidity gap, the years lived in poor health at the end of life, widened from 8.8 years in 1990 to 10.7 in 2023, in 203 of 204 countries, and widest in the richest. Ranked by evidence that a component adds healthy years at population scale: tobacco and alcohol policy first — taxation, marketing and availability controls — because they carry the largest, best-documented effects on both mortality and morbidity; delivery systems for vaccination and guideline screening second, where the interventions are proven and the infrastructure is the delivery; hypertension detection and control programmes third, the largest treatable risk with the cheapest treatment; primary and community pharmacy care that keeps chronic disease controlled fourth; air quality, active-travel and walkable urban design fifth, with strong observational and some quasi-experimental evidence; falls-prevention and healthy-ageing services sixth, backed by high-certainty trial evidence and chronically under-delivered; and longevity-science research funding last on this list, because it is important and has not yet added a healthy year to anyone. The commitments are real — Singapore's Healthier SG, the EU's legally reserved 20% prevention share — and the outcomes are not guaranteed, as the UK showed by promising five extra healthy years and recording its lowest healthy life expectancy on record.
- Infrastructure here means delivery: the interventions are mostly known, and the gap is whether a population receives them.
- The morbidity gap is widening almost everywhere and is largest in rich countries, which is the problem the infrastructure exists to solve.
- Tobacco and alcohol policy remain the most powerful longevity infrastructure any government owns.
- Commitment is not outcome: the UK set a healthy-years mission and recorded its lowest healthy life expectancy since records began.
- Inequality is the largest under-reported fact: a 19–20-year healthy-life-expectancy gap between richest and poorest deciles in England.
The components of public longevity infrastructure, ranked by evidence
Ranked on: the strength and size of evidence that the component adds healthy life-years at population scale, cost-effectiveness, and how much of the effect depends on delivery rather than discovery.
| # | Option | Verdict | Grade |
|---|---|---|---|
| 1 | Tobacco and alcohol policy | The largest, best-documented population effects | GRADE AEstablished |
| 2 | Vaccination and screening delivery systems | Proven interventions; the infrastructure is reaching people | GRADE AEstablished |
| 3 | Hypertension detection and control programmes | The largest treatable risk, the cheapest treatment | GRADE AEstablished |
| 4 | Primary and community pharmacy care | Keeps chronic disease controlled and medicines safe | GRADE AEstablished |
| 5 | Air quality, active travel and walkable urban design | Strong observational and quasi-experimental evidence | GRADE BPromising |
| 6 | Falls-prevention and healthy-ageing services | High-certainty trial evidence; chronically under-delivered | GRADE BPromising |
| 7 | Longevity-science research funding | Important; has not yet added a healthy year | GRADE CEarly |
- 01
Tobacco and alcohol policy
GRADE AEstablishedThe largest, best-documented population effectsTaxation, plain packaging, marketing and availability restrictions, minimum unit pricing, smoke-free laws. Decades of natural experiments show falls in consumption, cardiovascular events, cancers and deaths, with the largest gains among the poorest. The cheapest longevity infrastructure a state owns and the one industry fights hardest.
- 02
Vaccination and screening delivery systems
GRADE AEstablishedProven interventions; the infrastructure is reaching peopleRegistries, call-recall, pharmacy and community delivery, and outreach that gets influenza, pneumococcal, shingles and COVID vaccines and colorectal, breast, cervical and lung screening to the people due for them. The interventions have mortality evidence; uptake is the infrastructure, and it is where the gap between rich and poor areas opens.
- 03
Hypertension detection and control programmes
GRADE AEstablishedThe largest treatable risk, the cheapest treatmentPopulation blood-pressure screening (pharmacies, workplaces, community), protocol-driven treatment, and pharmacist-led titration. Hypertension control rates in most countries sit below half; each percentage point of control is strokes and heart attacks avoided. Among the highest-return programmes in public health.
- 04
Primary and community pharmacy care
GRADE AEstablishedKeeps chronic disease controlled and medicines safeAccessible primary care and community pharmacy delivering chronic-disease management, medication review and deprescribing, cessation support and vaccination. Countries with strong primary care have better outcomes at lower cost; pharmacy extends its reach to people who never see a doctor.
- 05
Air quality, active travel and walkable urban design
GRADE BPromisingStrong observational and quasi-experimental evidenceClean-air regulation and low-emission zones, safe cycling and walking infrastructure, parks and public transport. Air pollution is a leading cause of death; active travel raises physical activity across a population without asking anyone to join a gym. The evidence is observational and from natural experiments rather than trials, and consistently positive.
- 06
Falls-prevention and healthy-ageing services
GRADE BPromisingHigh-certainty trial evidence; chronically under-deliveredPhysiotherapist-led balance and strength programmes, hearing and vision services, home hazard assessment. Balance exercise cuts falls by 23% across 108 randomised trials; delivery is patchy, and fall deaths have risen in the years since the evidence was published. The clearest example of infrastructure as the missing piece.
- 07
Longevity-science research funding
GRADE CEarlyImportant; has not yet added a healthy yearGeroscience institutes, ageing-biology programmes, trials of repurposed drugs. Worth funding for what it may find; not yet infrastructure that changes a population's healthspan, and easily confused with it in a strategy document.
Why it matters now: the numbers behind the definition
The facts that make public longevity infrastructure urgent
| Fact | Figure | Source | What it implies |
|---|---|---|---|
| Global morbidity gap (life expectancy minus healthy life expectancy) | 8.8 years (1990) → 10.7 years (2023), +21.9% | GBD 2023, Lancet Public Health, Aug 2026 | Extra years are increasingly years in poor health |
| Countries where the gap widened | 203 of 204 (point estimates) | GBD 2023 | Not a local failure; a global pattern |
| Where the gap is largest | Highest-income (high-SDI) countries | GBD 2023 | Wealth is not buying healthy years efficiently |
| Healthy-life-expectancy gap, richest vs poorest decile, England | 19.1 years (men), 20.2 years (women) | ONS, 2020–2022 | Inequality is the biggest lever and the least reported |
| EU4Health prevention share | ≥20% of budget legally reserved | Reg. (EU) 2021/522 | A budget rule is the hardest commitment in the set |
| EU preventive spending | 3.7% of health expenditure in 2023, down 33.6% in a year | Eurostat | Commitments and spending diverge |
| UK healthy-years mission | Target: +5 healthy years by 2035; result: lowest HLE on record (ONS, Feb 2026) | UK government; ONS | Commitment is not outcome |
| Return on prevention | Median 14.3:1, with publication bias and method caveats | Masters et al. 2017 | Cost-effective; not reliably cost-saving |
Frequently asked questions
What is public longevity infrastructure?
The laws, budgets, services and physical environments a government uses to extend healthy life expectancy at population scale: tobacco and alcohol policy, vaccination and screening delivery systems, hypertension control programmes, primary and community pharmacy care, air-quality and active-travel design, falls-prevention and healthy-ageing services, and longevity research. The word infrastructure matters because the interventions are mostly known; what is built is the delivery.
Why does public longevity infrastructure matter now?
Because the morbidity gap — years lived in poor health at the end of life — has widened almost everywhere: from 8.8 years in 1990 to 10.7 in 2023 globally, in 203 of 204 countries, and most in the richest. Longer lives are increasingly longer periods of ill health, and the tools to change that are public, not private.
What is the most effective public longevity infrastructure?
Tobacco and alcohol policy — taxation, marketing and availability controls, minimum pricing — has the largest and best-documented population effects on both mortality and morbidity, with the biggest gains among the poorest. Vaccination and screening delivery, hypertension control programmes and strong primary and pharmacy care follow closely.
Do government longevity commitments work?
Only when delivered. Singapore's Healthier SG and the EU's legally reserved 20% prevention share are real commitments; EU preventive spending nonetheless fell a third in a year, and the UK, having set a mission of five extra healthy years by 2035, recorded its lowest healthy life expectancy since its series began. A budget rule is a harder commitment than a target, and neither is an outcome.
Is prevention infrastructure cost-saving?
Usually cost-effective, not reliably cost-saving. The often-quoted median return of 14.3:1 comes with publication bias and inconsistent methods, and healthy-living people accrue higher lifetime medical costs because they live longer. Prevention buys healthy years at good value; it should not be sold to treasuries as a saving.
How does community pharmacy fit into longevity infrastructure?
As delivery within walking distance: vaccination, blood-pressure checks and in some systems titration, smoking-cessation support, and medication reviews that remove the drugs causing falls and confusion in older adults. Pharmacies reach people who never see a doctor, which is where the healthy-life-expectancy gap is widest.
Keep reading
- Public health and policy
The GBD 2023 data, the commitments and the outcomes.
- What public longevity infrastructure strategies improve population health outcomes?
The strategies ranked.
- Smart longevity care robots with fall detection sensors.
Why falls prevention is infrastructure, not gadgets.
- Free stack check
The pharmacy's part of the infrastructure.
More in Public health & policy
- How to invest in public longevity infrastructure projects?
How private capital can invest in public longevity infrastructure, ranked by instrument and project type: municipal and sovereign health bonds, social and health impact bonds, public-private partnerships for primary-care and diagnostic facilities, listed healthcare-infrastructure and REIT exposure, and impact funds — with what returns are realistic, what 'longevity dividend' figures actually mean, and the questions to ask before committing.
- Which public longevity infrastructure solutions offer best ROI?
Public longevity infrastructure solutions ranked on return per healthy life-year with the evidence caveats stated: tobacco and alcohol taxation, salt and sugar policy, vaccination delivery, hypertension control, cessation services, falls-prevention exercise, screening programmes, active-travel infrastructure, and longevity clinics or research institutes — with why ROI figures vary from negative to 30:1 and what a treasury should actually expect.
- How can governments fund public longevity infrastructure effectively?
Funding mechanisms for public longevity infrastructure ranked on whether money reaches delivery and survives budget cycles: earmarked health taxes, legally reserved prevention shares (EU4Health's 20%), ring-fenced prevention budgets, outcome-linked payments, general taxation with performance frameworks, and one-off capital programmes — with the evidence from the EU, UK and Singapore on what holds and what evaporates.
- What public longevity infrastructure strategies improve population health outcomes?
Public longevity strategies ranked on recorded population-health outcomes: fiscal and regulatory control of tobacco, alcohol and diet; universal primary care with enrolment (Singapore's Healthier SG model); organised vaccination and screening with call-recall; hypertension control at scale; deprivation-targeted delivery to close the 20-year healthy-life gap; healthy-ageing services; and target-led strategies without delivery — with what each has actually changed.
- How to evaluate impact of public longevity infrastructure?
A ranked method for evaluating public longevity infrastructure: pick outcomes that matter (healthy life expectancy by deprivation, morbidity gap), use designs that can attribute (randomised rollouts, stepped-wedge, difference-in-differences, synthetic controls), track delivery and coverage first, measure equity, model cost-effectiveness honestly, and avoid the evaluation traps that let target-led strategies claim success.
- What public longevity infrastructure models attract private investors?
Public longevity infrastructure models ranked on attracting private capital without distorting the health objective: availability-payment PPPs for primary-care and diagnostic facilities, earmarked-revenue bonds, outcome-based contracts and impact bonds, blended-finance funds with public first-loss capital, and concession models for healthy-ageing services — with what investors actually need, what governments must protect, and the models that go wrong.